UNITED THERAPEUTICS Corp (UTHR)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 798,600 | 794,400 | 748,900 | 714,900 |
| Selling, general, and administrative | 212,500 | 170,100 | 219,200 | 177,600 |
| Research and development | 134,000 | 149,000 | 103,500 | 139,600 |
| Cost of sales | 87,600 | 92,500 | 83,100 | 77,800 |
| Total operating expenses | 434,100 | 411,600 | 405,800 | 395,000 |
| Operating income | 364,500 | 382,800 | 343,100 | 319,900 |
| Other (expense) income, net | -100 | -4,300 | 5,800 | 800 |
| Interest income | 51,300 | 51,100 | 49,800 | 46,200 |
| Interest expense | 7,300 | 6,100 | 10,100 | 11,600 |
| Total other income, net | 43,900 | 40,700 | 45,500 | 35,400 |
| Income before income taxes | 408,400 | 423,500 | 388,600 | 355,300 |
| Income tax expense | 98,900 | 101,300 | 79,500 | 77,200 |
| Net income | 309,500 | 322,200 | 309,100 | 278,100 |
| Basic (in dollars per share) | 6.86 | 7.18 | 6.93 | 6.26 |
| Basic (in shares) | 45,100,000 | 44,900,000 | 44,600,000 | 44,400,000 |
| Diluted (in dollars per share) | 6.41 | 6.63 | 6.39 | 5.85 |
| Diluted (in shares) | 48,300,000 | 48,600,000 | 48,400,000 | 47,500,000 |